Serebryany honored for work on cataracts
Growing up in Russia, Evgeny “Eugene” Serebryany mostly enjoyed humanities-related courses. He developed new interests after he moved to the U.S. as a teenager and faced a language barrier.
At his Massachusetts high school, Serebryany began to translate Russian poetry, which he still does, and he started to embrace science.

“Experimental science offered a way to contribute to advancement of knowledge in a very concrete way,” he said.
His path wasn’t always easy. “Immigration status has been the biggest roadblock,” he said.
As an international student, he wasn’t eligible for federal grants or loans for college, and his family couldn’t afford the tuition. Yale University offered him full financial aid from endowment funds, and he earned a bachelor’s degree in molecular biophysics and biochemistry while doing research in the laboratory of Elsa C. Y. Yan.
Federal training grants also cannot fund graduate students who lack permanent U.S. residency. The Massachusetts Institute of Technology granted Serebryany a private fellowship, and he completed his Ph.D. in biochemistry with Jonathan A. King. He is now a postdoctoral fellow in Eugene I. Shakhnovich’s research group at Harvard.
Serebryany said he is grateful to both Yale and MIT for the education he received “on their own dime.”
As a postdoc, he petitioned the U.S. government for a green card based on exceptional scientific ability in the national interest. His request was approved in February 2018, and he gained permanent resident status in time to receive the National Institutes of Health National Research Service Award, which now funds most of his research.
“I couldn’t travel abroad. Now I can,” he said. “But beyond the funding and travel restrictions, just the fear of someday not being able to extend my string of temporary statuses … and then having to leave or get deported, made it that much harder to focus on the research.
“The sense of freedom and security that a green card gives, though not complete, is priceless.”
Disulfide bonds offer new insights into cataracts
Cataracts impair vision by clouding the eye’s lens, mostly in older people. Most proteins in the lens belong to the crystallin family; as we age, the crystallin proteins can start to clump together, causing the lens to scatter light and become less transparent.
Serebryany and his colleagues used biochemical approaches including mass spectrometry and mutational analysis to develop new mechanistic insights into disulfide bond formation and exchange in crystallins, which led them to propose a “redox hot potato” competition model; under physiological conditions, stable gamma-crystallin molecules in the lens continually exchange disulfides. However, if a stable molecule passes the disulfide to a structurally unstable one, the latter becomes trapped in a structure prone to aggregation, which results in light scattering, the hallmark of cataracts.
Cataracts can be addressed in two ways. When prescription eyeglasses become ineffective, patients are left with the option of surgery, which is effective but expensive and not available to everyone. Cataracts remain the world’s leading cause of blindness. The work of Serebryany and his colleagues may pave the way to lower-cost therapeutic treatment.
Read his prize-winning paper here.
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition weekly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in People
People highlights or most popular articles

ASBMB names 2025 fellows
American Society for Biochemistry and Molecular Biology honors 24 members for their service to the society and accomplishments in research, education, mentorship, diversity and inclusion and advocacy.

When Batman meets Poison Ivy
Jessica Desamero had learned to love science communication by the time she was challenged to explain the role of DNA secondary structure in halting cancer cell growth to an 8th-grade level audience.

The monopoly defined: Who holds the power of science communication?
“At the official competition, out of 12 presenters, only two were from R2 institutions, and the other 10 were from R1 institutions. And just two had distinguishable non-American accents.”

In memoriam: Donald A. Bryant
He was a professor emeritus at Penn State University who discovered how cyanobacteria adapt to far-red light and was a member of the American Society for Biochemistry and Molecular Biology for over 35 years.

Yes, I have an accent — just like you
When the author, a native Polish speaker, presented her science as a grad student, she had to wrap her tongue around the English term “fluorescence cross-correlation microscopy.”

Professorships for Booker; scholarship for Entzminger
Squire Booker has been appointed to two honorary professorships at Penn State University. Inayah Entzminger received a a BestColleges scholarship to support their sixth year in the biochemistry Ph.D. program at CUNY.